<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35952496</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.</ArticleTitle><Pagination><StartPage>104208</StartPage><MedlinePgn>104208</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104208</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2022.104208</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(22)00390-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Better understanding of the association between characteristics of patients hospitalized with coronavirus disease 2019 (COVID-19) and outcome is needed to further improve upon patient management.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) is a prospective, observational study of 1164 patients from 20 hospitals across the United States. Disease severity was assessed using a 7-point ordinal scale based on degree of respiratory illness. Patients were prospectively surveyed for 1 year after discharge for post-acute sequalae of COVID-19 (PASC) through quarterly surveys. Demographics, comorbidities, radiographic findings, clinical laboratory values, SARS-CoV-2 PCR and serology were captured over a 28-day period. Multivariable logistic regression was performed.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">The median age was 59 years (interquartile range [IQR] 20); 711 (61%) were men; overall mortality was 14%, and 228 (20%) required invasive mechanical ventilation. Unsupervised clustering of ordinal score over time revealed distinct disease course trajectories. Risk factors associated with prolonged hospitalization or death by day 28 included age &#x2265; 65 years (odds ratio [OR], 2.01; 95% CI 1.28-3.17), Hispanic ethnicity (OR, 1.71; 95% CI 1.13-2.57), elevated baseline creatinine (OR 2.80; 95% CI 1.63- 4.80) or troponin (OR 1.89; 95% 1.03-3.47), baseline lymphopenia (OR 2.19; 95% CI 1.61-2.97), presence of infiltrate by chest imaging (OR 3.16; 95% CI 1.96-5.10), and high SARS-CoV2 viral load (OR 1.53; 95% CI 1.17-2.00). Fatal cases had the lowest ratio of SARS-CoV-2 antibody to viral load levels compared to other trajectories over time (p=0.001). 589 survivors (51%) completed at least one survey at follow-up with 305 (52%) having at least one symptom consistent with PASC, most commonly dyspnea (56% among symptomatic patients). Female sex was the only associated risk factor for PASC.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Integration of PCR cycle threshold, and antibody values with demographics, comorbidities, and laboratory/radiographic findings identified risk factors for 28-day outcome severity, though only female sex was associated with PASC. Longitudinal clinical phenotyping offers important insights, and provides a framework for immunophenotyping for acute and long COVID-19.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">NIH.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ozonoff</LastName><ForeName>Al</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical &amp; Data Coordinating Center (CDCC); Precision Vaccines Program, Boston Children's Hospital, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaenman</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayavelu</LastName><ForeName>Naresh Doni</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Benaroya Research Institute, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milliren</LastName><ForeName>Carly E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Clinical &amp; Data Coordinating Center (CDCC); Precision Vaccines Program, Boston Children's Hospital, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calfee</LastName><ForeName>Carolyn S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>University of California San Francisco School of Medicine, San Francisco, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cairns</LastName><ForeName>Charles B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Drexel University/Tower Health Hospital, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraft</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Arizona, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baden</LastName><ForeName>Lindsey R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Boston Clinical Site: Precision Vaccines Program, Boston Children's Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Yale School of Medicine, and Yale School of Public Health, New Haven, CT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krammer</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bakel</LastName><ForeName>Harm</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esserman</LastName><ForeName>Denise A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Yale School of Medicine, and Yale School of Public Health, New Haven, CT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical &amp; Data Coordinating Center (CDCC); Precision Vaccines Program, Boston Children's Hospital, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sesma</LastName><ForeName>Ana Fernandez</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Viviana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafler</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Yale School of Medicine, and Yale School of Public Health, New Haven, CT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Ruth R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Yale School of Medicine, and Yale School of Public Health, New Haven, CT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleinstein</LastName><ForeName>Steven H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Yale School of Medicine, and Yale School of Public Health, New Haven, CT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Ofer</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Boston Clinical Site: Precision Vaccines Program, Boston Children's Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bime</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Arizona, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddad</LastName><ForeName>Elias K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Drexel University/Tower Health Hospital, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erle</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>University of California San Francisco School of Medicine, San Francisco, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pulendran</LastName><ForeName>Bali</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Stanford University, Palo Alto, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadeau</LastName><ForeName>Kari C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Stanford University, Palo Alto, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Stanford University, Palo Alto, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hough</LastName><ForeName>Catherine L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Oregon Health Sciences University, Portland, OR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messer</LastName><ForeName>William B</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>Oregon Health Sciences University, Portland, OR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higuita</LastName><ForeName>Nelson I Agudelo</ForeName><Initials>NIA</Initials><AffiliationInfo><Affiliation>Oklahoma University Health Sciences Center, Oklahoma, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metcalf</LastName><ForeName>Jordan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Oklahoma University Health Sciences Center, Oklahoma, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkinson</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>University of Florida, Gainesville and University of South Florida, Tampa, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brakenridge</LastName><ForeName>Scott C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>University of Florida, Gainesville and University of South Florida, Tampa, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corry</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, and the Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kheradmand</LastName><ForeName>Farrah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, and the Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehrlich</LastName><ForeName>Lauren I R</ForeName><Initials>LIR</Initials><AffiliationInfo><Affiliation>The University of Texas at Austin, Austin, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melamed</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The University of Texas at Austin, Austin, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McComsey</LastName><ForeName>Grace A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Case Western Reserve University, Cleveland, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekaly</LastName><ForeName>Rafick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Case Western Reserve University, Cleveland, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diray-Arce</LastName><ForeName>Joann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical &amp; Data Coordinating Center (CDCC); Precision Vaccines Program, Boston Children's Hospital, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Bjoern</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>La Jolla Institute for Immunology, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Augustine</LastName><ForeName>Alison D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reed</LastName><ForeName>Elaine F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altman</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Benaroya Research Institute, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Patrice M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouphael</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Emory University, Atlanta, GA, United States. Electronic address: nroupha@emory.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>IMPACC study group members</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U19 AI090023</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI057229</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD026880</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI062629</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI077439</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI128910</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI104870</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI118626</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI167891</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI167903</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI125357</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI145835</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI128913</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI132774</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI118608</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AI142766</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI057266</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 AA027837</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI118610</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 HL141623</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI153559</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD030463</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI135803</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI089992</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014336">Troponin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>EBioMedicine. 2023 Dec;98:104860. doi: 10.1016/j.ebiom.2023.104860</RefSource><PMID Version="1">37918220</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014336" MajorTopicYN="N">Troponin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibody</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Viral load</Keyword></KeywordList><CoiStatement>Declaration of interests J.S reports funds paid to institution by the National Institute of Health - National Institute of Allergy and Infectious Diseases for the completion of this manuscript. C.S.C reports funds from NHLBI, has grants/contracts from Bayer, Roche-Genentech, Quantum Leap Healthcare Collaborative and received consulting fees from Vasomune, Gen1e Life Sciences, Cellenkos, Janssen. C.B.C reports funds paid to institution from the National Institute of Health - National Institute of Allergy and Infectious Diseases for the completion of this manuscript. C.B.C also reports a grant paid to institution by the Bill &amp; Melinda Gates Foundation for Covid-19 work. C.B.C is a consultant for bioMerieux on clinical biomarkers. He reports his participation on a data safety monitoring board or advisory board for the Convalescent plasma Covid-19 study for the National Heart, Lung and Blood Institute (NHLBI). CBC is also President, Board of Directors for the National Foundation of Emergency Medicine (NFEM), a non-profit supporting emergency medicine research and researchers. M.K reports funds paid to institution for grants or contracts from the National Institute of Health. L.B reports grant awarded to institution from the National Institute of Health - National Institute of Allergy and Infectious Diseases. A.C.S reports funds paid to institution by the National Institute of Health for the completion of this manuscript (NIH U19 AI089992 &#x2013; NIH K24 AG042489). F.KR has received funds from the National Institute of Allergy and Infectious Diseases Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051, the National Institute of Health - Centers of Excellence for influenza Research and Response, (CEIRR), 75N93021C00014, the JPB Foundation and the Open Philanthropy Project (research grant 2020-215611, 5384), the National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024, Task Order No. 75N91020F00003 and Research funding from Pfizer for development of animal models for SARS-CoV-2. F.KR receives royalties from Avimex, and receives consulting fees from Pfizer, Seqirus, Avimex and Third Rock Ventures. F.KR has received several payments or honoraria for academic lectures over the past two years. F. KR is listed as a co-inventor on patents filed for applications relating to SARS-CoV-2 serological assays (the &#x201c;Serology Assays&#x201d;) and NDV-based SARS-CoV-2 vaccines. H.vB reports receipt of the following grants paid to institution: National Institute of Health Centers of Excellence for influenza Research and Response, (CEIRR - 75N93021C00014), and National Institute of Health (Dengue Human Immunology Project Consortium - Mount Sinai IMPACC COVID-19 Cores - U19 AI118610 S1). D. E reports funds paid to institution for grants or contracts from the National Institute of Health. D.E is a statistician on the Data Safety Monitoring Board for the COLSTAT Trial. D.E is on the board of Directors for the Society for Clinical Trials. V.S is listed as a co-inventor on a patent filed relating to SARS-CoV-2 serological assays (the &#x201c;Serology Assays&#x201d;). R.M reports a grant from the National Institute of Health for the completion of this manuscript (AI 089992). R. M served as a Counselor for the Society of Leukocyte Biology from 2018 to 2021. S.K is a personal consultant related to ImmPort data repository for Peraton. O.L reports funds paid to institution by the National Institute of Health - National Institute of Allergy and Infectious Diseases for the completion of this manuscript (1-U19-AI118608-01A1). O.L received payments in the past 36 months from Midsized Bank Coalition of America (MBCA) and Moody's Analytics for presentations regarding the coronavirus pandemic. D.J.E reports funds paid to institution for grants or contracts from the National Institute of Health. K.C.N reports having received grants paid to institution from the following institutes in the past 36 months: National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Environmental Health Sciences (NIEHS), and Food Allergy Research &amp; Education (FARE). K.C.N receives consulting fees from Excellergy, Eli Lilly, Red Tree Ventures, and Phylaxis. K.C.N has one Licensee: Alladapt and Before Brands (Application number: US15/048,609) for Mixed allergen composition and methods for using the same. K.C.N has two patents issued: Granulocyte-based methods for detecting and monitoring immune system disorders (Application number: US12/686,121), and Methods and Assays for Detecting and Quantifying Pure Subpopulations of White Blood Cells in Immune System Disorders (Application number: US12/610,94). K.C.N is the director of the World Allergy Organization Center of Excellence for Stanford and a co-founder of Seed Health, IgGenix, ClostraBio, and ImmuneID. K.C.N is also a co-founder of Before Brands, Alladapt, and Latitude and an advisor for Cour Pharma. K.C.N is a member of the national scientific committee for the Immune Tolerance Network (ITN) and the National Institutes of Health (NIH) clinical research centers. C.L.H reports a grant awarded to institution by the National Institute of Health and the American Lung Association. C.L.H also reports having received consulting fees from the National Institute of Health. C.L.H has received payment for medical grand rounds at institution and support for attending meetings and/or travel from Critical care trialists, critical care reviews and multiple universities. C.L.H is on the data safety monitoring board of QuantumHealth for iSPY COVID and is on the board of directors for the American Thoracic Society. W.M reports a grant from the National Institute of Health &#x2013; National Institute of Allergy and Infectious Diseases for the completion of this manuscript (NIH NIAID R01AI14583). J.P.M reports funds paid to institution for grants or contracts from the National Institute of Health for the completion of this manuscript (NIH Grant # 3U19AI062629-17S2). M.A.A reports a grant from the National Institute of Health - National Institute of Allergy and Infectious Diseases for the completion of this manuscript (5U54AI142766-03). L.E reports grant awarded to institution from the National Institute of Health (NIH R01AI104870-S1). E.M reports funds paid to institution for grants or contracts from the National Institute of Health for the completion of this manuscript (NIH R01 AI104870S1). E.M also reports having received the following grants paid to institution in the past 36 months: the Babson Diagnostics Grant, the Austin Public Health Grant, and K08 26-1616-11. E.M received payments for lectures for the MS Association of America. E. M received payments for the participation in the advisory boards of Genentech, Horizon, Teva and Viela Bio. G.M receives consulting fees from Gilead. B.PE reports a grant from the National Institute of Health - National Institute of Allergy and Infectious Diseases for the completion of this manuscript. E.F.R reports funds paid to institution by the National Institute of Health - National Institute of Allergy and Infectious Diseases for the completion of this manuscript (NIAID U19AI12891303). M.C.A reports funds received from the National Institute of Health for the completion of this manuscript (NIH &#x2013; R01AI32774) and funding by the National Institute of Allergy and Infectious Diseases for travel to present data related to this study. P.M.B is a federal employee serving as project scientist for this project but has no role in funding decisions or oversight for relevant grants. N.R reports funds paid to institution by the National Institute of Health - National Institute of Allergy and Infectious Diseases for the completion of this manuscript. N.R reports contracts with Lilly and Sanofi for conduct of Covid-19 clinical trials. N.R receives consulting fees from ICON EMMES for consulting on safety for Covid-19 clinical trials. N.R is an associate editor for Clinical infectious diseases. The remaining authors declare that they have no conflict of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Ozonoff</LastName><ForeName>Al</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schaenman</LastName><ForeName>Joanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jayavelu</LastName><ForeName>Naresh Doni</ForeName><Initials>ND</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milliren</LastName><ForeName>Carly E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calfee</LastName><ForeName>Carolyn S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cairns</LastName><ForeName>Charles B</ForeName><Initials>CB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kraft</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baden</LastName><ForeName>Lindsey R</ForeName><Initials>LR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krammer</LastName><ForeName>Florian</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Bakel</LastName><ForeName>Harm</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Esserman</LastName><ForeName>Denise A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sesma</LastName><ForeName>Ana Fernandez</ForeName><Initials>AF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simon</LastName><ForeName>Viviana</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hafler</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Ruth R</ForeName><Initials>RR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kleinstein</LastName><ForeName>Steven H</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levy</LastName><ForeName>Ofer</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bime</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haddad</LastName><ForeName>Elias K</ForeName><Initials>EK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erle</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pulendran</LastName><ForeName>Bali</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadeau</LastName><ForeName>Kari C</ForeName><Initials>KC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davis</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hough</LastName><ForeName>Catherine L</ForeName><Initials>CL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Messer</LastName><ForeName>William B</ForeName><Initials>WB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Higuita</LastName><ForeName>Nelson I Agudelo</ForeName><Initials>NIA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Metcalf</LastName><ForeName>Jordan P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Atkinson</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brakenridge</LastName><ForeName>Scott C</ForeName><Initials>SC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corry</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kheradmand</LastName><ForeName>Farrah</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ehrlich</LastName><ForeName>Lauren I R</ForeName><Initials>LIR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Melamed</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McComsey</LastName><ForeName>Grace A</ForeName><Initials>GA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sekaly</LastName><ForeName>Rafick</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diray-Arce</LastName><ForeName>Joann</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peters</LastName><ForeName>Bjoern</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Augustine</LastName><ForeName>Alison D</ForeName><Initials>AD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reed</LastName><ForeName>Elaine F</ForeName><Initials>EF</Initials></Investigator><Investigator ValidYN="Y"><LastName>McEnaney</LastName><ForeName>Kerry</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barton</LastName><ForeName>Brenda</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lentucci</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saluvan</LastName><ForeName>Mehmet</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chang</LastName><ForeName>Ana C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoch</LastName><ForeName>Annmarie</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Albert</LastName><ForeName>Marisa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaheen</LastName><ForeName>Tanzia</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kho</LastName><ForeName>Alvin T</ForeName><Initials>AT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomas</LastName><ForeName>Sanya</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Jing</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Maimouna D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooney</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Presnell</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fragiadakis</LastName><ForeName>Gabriela K</ForeName><Initials>GK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Ravi</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guan</LastName><ForeName>Leying</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gygi</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pawar</LastName><ForeName>Shrikant</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brito</LastName><ForeName>Anderson</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khalil</LastName><ForeName>Zain</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maguire</LastName><ForeName>Cole</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fourati</LastName><ForeName>Slim</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Overton</LastName><ForeName>James A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vita</LastName><ForeName>Randi</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Westendorf</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salehi-Rad</LastName><ForeName>Ramin</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leligdowicz</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matthay</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singer</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kangelaris</LastName><ForeName>Kirsten N</ForeName><Initials>KN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendrickson</LastName><ForeName>Carolyn M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krummel</LastName><ForeName>Matthew F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Langelier</LastName><ForeName>Charles R</ForeName><Initials>CR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woodruff</LastName><ForeName>Prescott G</ForeName><Initials>PG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Powell</LastName><ForeName>Debra L</ForeName><Initials>DL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>James N</ForeName><Initials>JN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simmons</LastName><ForeName>Brent</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goonewardene</LastName><ForeName>I Michael</ForeName><Initials>IM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Cecilia M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martens</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mosier</LastName><ForeName>Jarrod</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kimura</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sherman</LastName><ForeName>Amy C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walsh</LastName><ForeName>Stephen R</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Issa</LastName><ForeName>Nicolas C</ForeName><Initials>NC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dela Cruz</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farhadian</LastName><ForeName>Shelli</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iwasaki</LastName><ForeName>Akiko</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ko</LastName><ForeName>Albert I</ForeName><Initials>AI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chinthrajah</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahuja</LastName><ForeName>Neera</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rogers</LastName><ForeName>Angela J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Artandi</LastName><ForeName>Maja</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siegel</LastName><ForeName>Sarah A R</ForeName><Initials>SAR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lu</LastName><ForeName>Zhengchun</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drevets</LastName><ForeName>Douglas A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Brent R</ForeName><Initials>BR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guirgis</LastName><ForeName>Faheem W</ForeName><Initials>FW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thyagarajan</LastName><ForeName>Rama V</ForeName><Initials>RV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rousseau</LastName><ForeName>Justin F</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wylie</LastName><ForeName>Dennis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Busch</LastName><ForeName>Johanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gandhi</LastName><ForeName>Saurin</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Triplett</LastName><ForeName>Todd A</ForeName><Initials>TA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yendewa</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giddings</LastName><ForeName>Olivia</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Evan J</ForeName><Initials>EJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>Aneesh K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sevransky</LastName><ForeName>Jonathan E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khor</LastName><ForeName>Bernard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rahman</LastName><ForeName>Adeeb</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stadlbauer</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dutta</LastName><ForeName>Jayeeta</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xie</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim-Schulze</LastName><ForeName>Seunghee</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez-Reiche</LastName><ForeName>Ana Silvia</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>van de Guchte</LastName><ForeName>Adriana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farrugia</LastName><ForeName>Keith</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Zenab</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maecker</LastName><ForeName>Holden T</ForeName><Initials>HT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elashoff</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brook</LastName><ForeName>Jenny</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramires-Sanchez</LastName><ForeName>Estefania</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Llamas</LastName><ForeName>Megan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivera</LastName><ForeName>Adreanne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perdomo</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ward</LastName><ForeName>Dawn C</ForeName><Initials>DC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magyar</LastName><ForeName>Clara E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fulcher</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abe-Jones</LastName><ForeName>Yumiko</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asthana</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beagle</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhide</LastName><ForeName>Sharvari</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carrillo</LastName><ForeName>Sidney A</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chak</LastName><ForeName>Suzanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fragiadakis</LastName><ForeName>Gabriela K</ForeName><Initials>GK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ghale</LastName><ForeName>Rajani</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jauregui</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Norman</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lea</LastName><ForeName>Tasha</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Deanna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lota</LastName><ForeName>Raphael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milush</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Viet</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pierce</LastName><ForeName>Logan</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prasad</LastName><ForeName>Priya A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rao</LastName><ForeName>Arjun</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samad</LastName><ForeName>Bushra</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Cole</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sigman</LastName><ForeName>Austin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sinha</LastName><ForeName>Pratik</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ward</LastName><ForeName>Alyssa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Willmore</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhan</LastName><ForeName>Jenny</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rashid</LastName><ForeName>Sadeed</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Nicklaus</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tang</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Altamirano</LastName><ForeName>Luz Torres</ForeName><Initials>LT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Betancourt</LastName><ForeName>Legna</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Curiel</LastName><ForeName>Cindy</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sutter</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paz</LastName><ForeName>Maria Tercero</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tietje-Ulrich</LastName><ForeName>Gayelan</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leroux</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Connors</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernui</LastName><ForeName>Mariana</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kutzler</LastName><ForeName>Michel A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edwards</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lin</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Croen</LastName><ForeName>Brett</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Semenza</LastName><ForeName>Nicholas C</ForeName><Initials>NC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rogowski</LastName><ForeName>Brandon</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Melnyk</LastName><ForeName>Nataliya</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woloszczuk</LastName><ForeName>Kyra</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cusimano</LastName><ForeName>Gina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>Mathew R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Furukawa</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McLin</LastName><ForeName>Renee</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marrero</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheidy</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tegos</LastName><ForeName>George P</ForeName><Initials>GP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagle</LastName><ForeName>Crystal</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mege</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ulring</LastName><ForeName>Kristen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seyfert-Margolis</LastName><ForeName>Vicki</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conway</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Francisco</LastName><ForeName>Dave</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Molzahn</LastName><ForeName>Allyson</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erickson</LastName><ForeName>Heidi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilson</LastName><ForeName>Connie Cathleen</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schunk</LastName><ForeName>Ron</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sierra</LastName><ForeName>Bianca</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hughes</LastName><ForeName>Trina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smolen</LastName><ForeName>Kinga</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desjardins</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Haren</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitre</LastName><ForeName>Xhoi</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cauley</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaofang</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tong</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Bethany</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montesano</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Licona</LastName><ForeName>Jose Humberto</ForeName><Initials>JH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krauss</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chang</LastName><ForeName>Jun Bai Park</ForeName><Initials>JBP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Izaguirre</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Omkar</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coppi</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fournier</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohanty</LastName><ForeName>Subhasis</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muenker</LastName><ForeName>M Catherine</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nelson</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raddassi</LastName><ForeName>Khadir</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rainone</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruff</LastName><ForeName>William E</ForeName><Initials>WE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salahuddin</LastName><ForeName>Syim</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schulz</LastName><ForeName>Wade L</ForeName><Initials>WL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vijayakumar</LastName><ForeName>Pavithra</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Haowei</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wunder</LastName><ForeName>Elsio</ForeName><Initials>E</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Young</LastName><ForeName>H Patrick</ForeName><Initials>HP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yujiao</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saksena</LastName><ForeName>Miti</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Altman</LastName><ForeName>Deena</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kojic</LastName><ForeName>Erna</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Srivastava</LastName><ForeName>Komal</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eaker</LastName><ForeName>Lily Q</ForeName><Initials>LQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berm&#xfa;dez-Gonz&#xe1;lez</LastName><ForeName>Maria C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beach</LastName><ForeName>Katherine F</ForeName><Initials>KF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sominsky</LastName><ForeName>Levy A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azad</LastName><ForeName>Arman R</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carre&#xf1;o</LastName><ForeName>Juan Manuel</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Gagandeep</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raskin</LastName><ForeName>Ariel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tcheou</LastName><ForeName>Johnstone</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bielak</LastName><ForeName>Dominika</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kawabata</LastName><ForeName>Hisaaki</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mulder</LastName><ForeName>Lubbertus Cf</ForeName><Initials>LC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kleiner</LastName><ForeName>Giulio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Alexandra S</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Do</LastName><ForeName>Evan Do</ForeName><Initials>ED</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manohar</LastName><ForeName>Monali</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hagan</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blish</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Din</LastName><ForeName>Hena Naz</ForeName><Initials>HN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roque</LastName><ForeName>Jonasel</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brunton</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strnad</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyski</LastName><ForeName>Zoe L</ForeName><Initials>ZL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coulter</LastName><ForeName>Felicity J</ForeName><Initials>FJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Booth</LastName><ForeName>J Leland</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sinko</LastName><ForeName>Lauren A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moldawer</LastName><ForeName>Lyle L</ForeName><Initials>LL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borresen</LastName><ForeName>Brittany</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roth-Manning</LastName><ForeName>Brittney</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Song</LastName><ForeName>Li-Zhen</ForeName><Initials>LZ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nelson</LastName><ForeName>Ebony</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis-Smith</LastName><ForeName>Megan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Jacob</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tipan</LastName><ForeName>Pablo Guaman</ForeName><Initials>PG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siles</LastName><ForeName>Nadia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bazzi</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Geltman</LastName><ForeName>Janelle</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hurley</LastName><ForeName>Kerin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabriele</LastName><ForeName>Gio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sieg</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vaysman</LastName><ForeName>Tatyana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bristow</LastName><ForeName>Laurel</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hussaini</LastName><ForeName>Laila</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hellmeister</LastName><ForeName>Kieffer</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samaha</LastName><ForeName>Hady</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheng</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spainhour</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scherer</LastName><ForeName>Erin M</ForeName><Initials>EM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Brandi</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bechnak</LastName><ForeName>Amer</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciric</LastName><ForeName>Caroline R</ForeName><Initials>CR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hewitt</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carter</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mcnair</LastName><ForeName>Nina</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panganiban</LastName><ForeName>Bernadine</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huerta</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Usher</LastName><ForeName>Jacob</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Susan Pereira</ForeName><Initials>SP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Altman</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Becker</LastName><ForeName>Patrice M</ForeName><Initials>PM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rouphael</LastName><ForeName>Nadine</ForeName><Initials>N</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35952496</ArticleId><ArticleId IdType="pmc">PMC9359694</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2022.104208</ArticleId><ArticleId IdType="pii">S2352-3964(22)00390-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arunachalam PS, Wimmers F, Mok CKP, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369(6508):1210&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunophenotyping assessment in a COVID-19 cohort (IMPACC): a prospective longitudinal study. Sci Immunol. 2021;6(62)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8713959</ArticleId><ArticleId IdType="pubmed">34376480</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453&#x2013;1457.</Citation><ArticleIdList><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>World health organization. WHO R&amp;D blueprint novel coronavirus COVID-19 therapeutic trial synopsis. 2020.https://www.who.int/blueprint/priority-diseases/key-action/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdf. Accessed 18 February 2020.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Research use only 2019-novel coronavirus (2019-nCoV) real-time RT-PCR primers and probes. 2020, June 6. https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html.</Citation></Reference><Reference><Citation>Gonzalez-Reiche AS, Hernandez MM, Sullivan MJ, et al. Introductions and early spread of SARS-CoV-2 in the New York City area. Science. 2020;369(6501):297&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7259823</ArticleId><ArticleId IdType="pubmed">32471856</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat F, Stadlbauer D, Strohmeier S, et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020;26(7):1033&#x2013;1036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183627</ArticleId><ArticleId IdType="pubmed">32398876</ArticleId></ArticleIdList></Reference><Reference><Citation>Imam Z, Odish F, Gill I, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med. 2020;288(4):469&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300881</ArticleId><ArticleId IdType="pubmed">32498135</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackey K, Ayers CK, Kondo KK, et al. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths: a systematic review. Ann Intern Med. 2021;174(3):362&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7772883</ArticleId><ArticleId IdType="pubmed">33253040</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, et al. Features of 20&#x2009;133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. Bmj. 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Mostert C, Hentschker C, et al. Case characteristics, resource use, and outcomes of 10&#x2008;021 patients with COVID-19 admitted to 920 German hospitals: an observational study. The Lancet Respiratory medicine. 2020;8(9):853&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386882</ArticleId><ArticleId IdType="pubmed">32735842</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevention CfDCa. Hospitalization and Death by Race/Ethnicity. September 9, 2021 2021. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html.</Citation></Reference><Reference><Citation>Argyropoulos KV, Serrano A, Hu J, et al. Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms. Am J Pathol. 2020;190(9):1881&#x2013;1887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332909</ArticleId><ArticleId IdType="pubmed">32628931</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang JT, Ran RX, Lv ZH, et al. Chronological changes of viral shedding in adult inpatients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71(16):2158&#x2013;2166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314240</ArticleId><ArticleId IdType="pubmed">32445580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Guo X, Xin Q, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients. Clin Infect Dis. 2020;71(10):2688&#x2013;2694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314147</ArticleId><ArticleId IdType="pubmed">32497196</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BE, Ong SWX, Ng LFP, et al. Viral dynamics and immune correlates of coronavirus disease 2019 (COVID-19) severity. Clin Infect Dis. 2021;73(9):e2932&#x2013;e2942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499509</ArticleId><ArticleId IdType="pubmed">32856707</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentsch CT, Kidwai-Khan F, Tate JP, et al. Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: a nationwide cohort study. PLoS Med. 2020;17(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7508372</ArticleId><ArticleId IdType="pubmed">32960880</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth GA, Emmons-Bell S, Alger HM, et al. Trends in patient characteristics and COVID-19 in-hospital mortality in the United States during the COVID-19 pandemic. JAMA Netw Open. 2021;4(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094014</ArticleId><ArticleId IdType="pubmed">33938933</ArticleId></ArticleIdList></Reference><Reference><Citation>Garibaldi BT, Fiksel J, Muschelli J, et al. Patient trajectories among persons hospitalized for COVID-19: a cohort study. Ann Intern Med. 2021;174(1):33&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530643</ArticleId><ArticleId IdType="pubmed">32960645</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan N, Schick F, H&#xe4;ring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26(2):292&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">28768170</ArticleId></ArticleIdList></Reference><Reference><Citation>Soeroto AY, Soetedjo NN, Purwiga A, et al. Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: a systematic review and meta-analysis. Diabetes Metab Syndr. 2020;14(6):1897&#x2013;1904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521380</ArticleId><ArticleId IdType="pubmed">33007661</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura H, Francisco D, Conway M, et al. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol. 2020;146(1):80&#x2013;88.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227558</ArticleId><ArticleId IdType="pubmed">32422146</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg E, Ben Zvi H, Sheena L, et al. A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel. Clin Microbiol Infect. 2021;27(6):917.e1&#x2013;917.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7939997</ArticleId><ArticleId IdType="pubmed">33705849</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R, Zhu C, Jian W, et al. Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients. Eur J Pharmacol. 2020;889</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490250</ArticleId><ArticleId IdType="pubmed">32941927</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogliati Dezza F, Oliva A, Cancelli F, et al. Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection. Diagn Microbiol Infect Dis. 2021;100(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879029</ArticleId><ArticleId IdType="pubmed">33639375</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan KH, Lui GCY, Poon KCF, et al. Ocular surface disturbance in patients after acute COVID-19. Clin Exp Ophthalmol. 2022;50(4):398&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111848</ArticleId><ArticleId IdType="pubmed">35218134</ArticleId></ArticleIdList></Reference><Reference><Citation>Binotti W, Hamrah P. COVID-19-related conjunctivitis review: clinical features and management. Ocul Immunol Inflamm. 2022:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35394858</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain, Behav Immunity. 2022;103:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano LD ES, Strid P, et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status &#x2014; United States, January 22&#x2013;October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1641&#x2013;1647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7643892</ArticleId><ArticleId IdType="pubmed">33151921</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena GE, Martinez PP, Mahmud AS, Marquet PA, Buckee CO, Santillana M. Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science. 2021;372(6545):eabg5298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158961</ArticleId><ArticleId IdType="pubmed">33906968</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xf6;lfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M-C, Cui C, Shin K-R, et al. Duration of culturable SARS-CoV-2 in hospitalized patients with Covid-19. N Engl J Med. 2021;384(7):671&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934323</ArticleId><ArticleId IdType="pubmed">33503337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajnberg A, Amanat F, Firpo A, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370(6521):1227&#x2013;1230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810037</ArticleId><ArticleId IdType="pubmed">33115920</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>